Obesity Services & Products

  1. Your Strategic Partner With A Global Network Of Support 5/20/2026

    With ParexelAI™, you're not just optimizing your current development timeline, you're unlocking the ability to run more programs simultaneously across our global network and compress critical timelines. In a landscape where speed to market directly impacts patient outcomes, ParexelAI empowers you to innovate and make a meaningful difference in patients' lives.

  2. Capture Cleaner, Higher-Quality Trial Data With Integrated eSource 5/13/2026

    Streamline clinical trial data capture through eSource workflows that support both Direct Data Capture and automated EHR-to-EDC data transfer across Paradigm Health’s research-ready provider network.

    Research teams can capture study data within the EHR or through a standalone application, enabling consistent workflows across sites while reducing manual transcription. Sponsors gain faster access to cleaner trial data with fewer queries and more efficient monitoring.

  3. Accelerate Participant Enrollment With Better Site Matches 5/11/2026

    With 150+ active sites and partner networks, Altasciences connects your clinical study to optimal locations and patients to reduce risk, accelerate enrollment, and stay on track.

  4. Portfolio Optimization Strategic Consulting 5/5/2026

    For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.

    In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.

  5. TrialKit AI: Intelligence For Clinical Trials 4/29/2026

    Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.

  6. Central Laboratory Services For Multi-Site Studies 4/28/2026

    At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.

  7. Trial Enablement Solutions 4/14/2026

    Digital health technologies have the potential to transform clinical trials, yet without careful planning and support, their implementation can increase site burden and jeopardize data quality.

  8. Patient Retention In Clinical Trials And Recruitment Support 4/9/2026

    Accelerate clinical trials with expert patient recruitment strategies delivering faster enrollment, lower dropout rates, and better outcomes.

  9. Post-Marketing Studies And Real-World Evidence Clinical Trials 4/9/2026

    Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.

  10. Drug Safety And Pharmacovigilance Services 4/2/2026

    Navigating drug safety in the era of innovation-driven medicine

    The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.